The Comprehensive, Computable NanoString Diagnostic gene panel (C2Dx) is a promising solution to address the need for a molecular pathological research and diagnostic tool for precision oncology utilizing small volume tumor specimens. We translate subtyping-related gene expression patterns of Non-Small Cell Lung Cancer (NSCLC) derived from public transcriptomic data which establish a highly robust and accurate subtyping system. The C2Dx demonstrates supreme performance on the NanoString platform using microgram-level FNA samples and has excellent portability to frozen tissues and RNA-Seq transcriptomic data. This workflow shows great potential for research and the clinical practice of cancer molecular diagnosis.
Keywords: cancer subtyping; elastic net regularization; fine needle aspiration; logistic regression; molecular signature; non-small cell lung cancer.
Copyright © 2021 Su, Huang, Barnard, Parks, Cappellari, Bellinger, Dotson, Craddock, Prakash, Hovda, Clark, Petty, Pasche, Chan, Miller and Ruiz.